The Breast Cancer Liquid Biopsy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Breast Cancer Liquid Biopsy Market?
The market size of the breast cancer liquid biopsy market has expanded quickly in the past few years. The value of the market will rise from $0.78 billion in 2024 to $0.90 billion in 2025, showing a compound annual growth rate (CAGR) of 15.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Breast Cancer Liquid Biopsy Industry?
In 2029, the breast cancer liquid biopsy market is anticipated to reach a value of $1.56 billion, with a compound annual growth rate (CAGR) of 14.7%.
Download Your Free Sample of the 2025 Breast Cancer Liquid Biopsy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Breast Cancer Liquid Biopsy Market?
The key drivers in the breast cancer liquid biopsy market are:
• Advancements in liquid biopsy assays technology
• Rising adoption of liquid biopsy for early cancer screening
• Increasing demand for real-time cancer monitoring
• Expansion of applications in precision oncology
Global Market Segmentation: Identifying Major Breast Cancer Liquid Biopsy Industry Segments
The breast cancer liquid biopsy market covered in this report is segmented –
1) By Product: Consumables, Kits
2) By Biomarkers: Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), Other Biomarkers
3) By Application: Early Detection Or Screening, Diagnosis, Other Applications
4) By End Users: Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories
Subsegments:
1) By Consumables: Reagents, Polymerase Chain Reaction (PCR) Assays, Sequencing Panels, Sample Collection Tubes
2) By Kits: DNA-based Liquid Biopsy Kits, RNA-based Liquid Biopsy Kits, Multi-marker Liquid Biopsy Kits
Pre-order the 2025 Breast Cancer Liquid Biopsy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Breast Cancer Liquid Biopsy Market?
The key trends in the breast cancer liquid biopsy market are:
• Artificial intelligence integration in liquid biopsy analysis is an emerging trend in the market.
• There is a rise in advancements in single-cell sequencing techniques.
• The development of multi-omics liquid biopsy platforms is shaping the future of the market.
• The trends also include improvements in liquid biopsy sensitivity and specificity as well as adoption of digital pcr for ultra-precision mutation detection.
Who Are the Top Competitors & Leading Players in the Breast Cancer Liquid Biopsy Market?
Major players in the breast cancer liquid biopsy market are:
• Johnson & Johnson Private Limited
• Roche Diagnostics
• Merck KGaA
• Thermo Fisher Scientific
• Siemens Healthineers
• Agilent Technologies Inc.
• Illumina Inc.
• Sysmex Corporation
• Qiagen N.V.
• Myriad Genetics Inc.
• NeoGenomics Laboratories
• Guardant Health Inc.
• Twist Bioscience
• Foundation Medicine Inc.
• Biodesix Inc.
• Menarini Silicon Biosystems
• Datar Cancer Genetics
• Abcam plc
• OncoDNA SA
• Genomic Health Inc.
• RainDance Technologies
• Biocept Inc.
• Fluxion Biosciences Inc.
• Angle plc
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the breast cancer liquid biopsy market in 2024
